CrossRef The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathy He Sun, Tong Chen, Xin Li, Yonghong Zhu, Shuang Zhang, Ping He, Yali Peng, Qiuling Fan Diabetology & Metabolic Syndrome.2023;[Epub] CrossRef Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy Jian Lu, Xue Qi Li, Pei Pei Chen, Jia Xiu Zhang, Liang Liu, Gui Hua Wang, Xiao Qi Liu, Ting Ting Jiang, Meng Ying Wang, Wen Tao Liu, Xiong Zhong Ruan, Kun Ling Ma JCI Insight.2023;[Epub] CrossRef SET7, a lysine-specific methyl transferase: An intriguing epigenetic target to combat diabetic nephropathy Samarth Dwivedi, Atharva Chavan, Atish T
Additionally, they validated DPP-IV mRNA levels in 18 THCA tissues and paracancerous tissues and confirmed DPP-IV protein levels in 12 medullary thyroid carcinoma (MTC) tissues using immunohistochemistry
Researchers administered a daily intraperitoneal dose of exenatide (5 nmol/kg body weight) to 11-month-old mice , continuing the treatment for 30 weeks [10]
Always start with the lowest dose and escalate gradually every four weeks
Or even 12 mg